Stealth Omicron Can’t Hide Its Lethality
Individuals who’ve been vaccinated and those vaccinated who’ve also gotten a booster are less likely to become infected by either Omicron or stealth Omicron, the study states.
A subvariant of Omicron, dubbed “stealth Omicron” is “substantially” more transmissible than the original variant and poses a greater threat to vaccinated and booster-upped individuals, according to a
“We conclude that Omicron BA.2 is inherently substantially more transmissible than BA.1, and that it also possesses immune-evasive properties that further reduce the protective effect of vaccination against infection, but do not increase its transmissibility from vaccinated individuals with breakthrough infections,” states the study, which was published on medRxiv website.
Investigators with the University of Copenhagen analyzed data taken from 8541 Danish households between December 20, 2021, and January 11, 2022. They found that individuals infected by stealth Omicron were 33% more likely to infect others, compared to original Omicron.
The study’s lead author Frederik Plesner Lyngse, PhD, told
Lyngse said in a recent
Stealth Omicron has also been detected in the United States, Norway, the United Kingdom, and Sweden, but not to the extent that it’s been detected in Denmark where, as of the second week in January, it accounted for 82% of new COVID-19 cases.
Individuals who’ve been vaccinated and those vaccinated who’ve also gotten a booster are less likely to become infected by either Omicron or stealth Omicron, the study states.
“We found BA.2 to be associated with an increased susceptibility of infection for unvaccinated individuals (Odds Ratio (OR) 2.19; 95%-CI 1.58-3.04), fully vaccinated individuals (OR 2.45; 95%-CI 1.77-3.40) and booster-vaccinated individuals (OR 2.99; 95%-CI 2.11-4.24), compared to BA.1,” the study states. “We also found an increased transmissibility from unvaccinated primary cases in BA.2 households when compared to BA.1 households, with an OR of 2.62 (95%-CI 1.96-3.52).”
Omicron was first noticed in South Africa. Tulio de Oliveira, PhD, who directs South Africa's Centre for Epidemic Response and Innovation, said in a recent
Eric Topol, MD, founder and director of the Scripps Research Translational Institute, said in a recent
Newsletter
Related Articles
- Bug of the Month: I'm Older Than Empires
September 16th 2025
- Top 5 Infection Prevention Articles of Summer 2025
September 16th 2025
- From Outbreak to Zoopocalypse: 11 More Must-Watch Viral Thrillers
September 15th 2025
- Debunking the Mistruths and Misinformation About COVID-19
September 15th 2025
- Bug of the Month: I Like to Hitch a Ride
September 12th 2025